Factors Influencing the Emergence and Spread of HIV Drug Resistance Arising from Rollout of Antiretroviral Pre-Exposure Prophylaxis (PrEP)

Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men

(2010) Robert M. Grant et al.   NEW ENGLAND JOURNAL OF MEDICINE

HIV, transmitted drug resistance, and the paradox of preexposure prophylaxis

(2010) V. Supervie et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

HIV Preexposure Prophylaxis in the United States: Impact on Lifetime Infection Risk, Clinical Outcomes, and Cost‐Effectiveness

(2009) A. David Paltiel et al.   CLINICAL INFECTIOUS DISEASES

Circulating HIV Type 1 Drug Resistance Will Have Limited Impact on the Effectiveness of Preexposure Prophylaxis among Young Women in Zimbabwe

(2009) David A. M. C. van de Vijver et al.   JOURNAL OF INFECTIOUS DISEASES

Oral pre-exposure prophylaxis for HIV prevention

(2009) J. Gerardo García-Lerma et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness

(2008) Kamal Desai et al.   AIDS

The Impact of Pre-Exposure Prophylaxis (PrEP) on HIV Epidemics in Africa and India: A Simulation Study

(2008) Debby C. J. Vissers et al.   PLoS One

Prevention of Rectal SHIV Transmission in Macaques by Daily or Intermittent Prophylaxis with Emtricitabine and Tenofovir

(2008) J. Gerardo García-Lerma et al.   PLOS MEDICINE

Minority HIV-1 Drug Resistance Mutations Are Present in Antiretroviral Treatment–Naïve Populations and Associate with Reduced Treatment Efficacy

(2008) Jeffrey A Johnson et al.   PLOS MEDICINE